abstract |
The present invention relates to compounds of formula (I), which are suitable for the treatment of diseases mediated by TNF-α, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage rarefaction. |